Nano-Hydroxyapatite Doped with Ho-166 as Drug Delivery System for Bone Cancer Therapy and Diagnosis: Developing a Theragnostic Radiopharmaceuticals

Author(s): Franciana Maria Rosa da Silva, Julio Cezar de Almeida, Elizabeth Eugenio de Mello Oliveira, Marta de Souza Albernaz, Alexandre Malta Rossi, Ralph Santos-Oliveira.

Journal Name: Anti-Cancer Agents in Medicinal Chemistry

Volume 17 , Issue 3 , 2017

Submit Manuscript
Submit Proposal

Graphical Abstract:


Abstract:

Background: The use of nanobiomaterials is increasing each day. Among the immense variety of nanomaterials developed and studied the hydroxyapatite is one of the most ones.

Objective: In this study we developed and tested nano-hydroxyapatite dopped with Ho-166 for bone cancer.

Results: The results showed that the nano-hydroxyapatite dopped with Ho-166 has a great affinity for the bone.

Conclusion: The pre-clinical studies support the use as a nano-radiopharmaceuticals for bone cancer treatment and diagnosis.

Keywords: Radiopharmaceuticals, nanotechnology, oncology, scanning electron microscopy, transmission electron microscopy.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 17
ISSUE: 3
Year: 2017
Page: [355 - 358]
Pages: 4
DOI: 10.2174/1871520616666151110130428
Price: $58

Article Metrics

PDF: 26
HTML: 2